This revised application focuses on the roles and mechanisms of Insulin-like growth factor (IGF-I) and IGF binding proteins (IGFBPs) in intestinal adaptation. Systemic growth hormone (GH) and IGF-I promote intestinal adaptation in an endocrine manner. IGF-I mediates many of the actions of GH in bowel. Clinical trials of GH and IGF-I as therapy for short bowel syndrome and other bowel diseases are in progress. Yet, there is virtually no direct information about the intracellular mechanisms of IGF-I action in bowel. Adaptive changes in growth of small bowel mucosa correlate with levels of locally expressed IGF-I indicating paracrine or autocrine effects of IGF-I in bowel. GH increases local expression of IGF-I within small bowel. The role of locally expressed IGF-I in adaptive growth of the small bowel mucosa is not defined. This information is critical for understanding the relative benefits of therapy with systemic IGF-I compared with GH in patients with bowel disease. As well as IGF-I, mucosal mesenchymal cells express three IGFBPs, IGFBP3, IGFBP4 and IGFBP5. Local expression of IGFBPs is altered during adaptive growth of bowel mucosa. The actions of locally expressed IGF-I on mucosal growth likely depend on whether IGF-I is secreted into the extracellular fluid, whether secreted IGF-I associates with secreted IGFBPs and whether IGF-I is sequestered onto the cell surface or extracellular matrix via interactions with IGFBPs.
Specific aim 1 will use SMP- IGF-I transgenic mice to test the hypothesis that mesenchymal cell derived IGF-I alters growth and function of bowel in vivo. Small bowel of SMP- IGF-I and WT mice will be compared for mucosal mass, crypt cell proliferation, apoptosis and brush border enzyme activities to define the role of locally expressed, mesenchymal cell derived IGF-I in regulating mucosal growth and function.
Specific aim 2 will use IRS-1 null mice and IRS-1 null/SMP- IGF-I crossbreeds tot test the hypothesis that IRS-1 mediates cell specific, trophic actions of IGF-I on bowel.
Specific aim 3 will test the hypothesis that differences in expression of IGFs/IGFBPs mediate phenotypic differences in two intestinal fibroblast subtypes and/or their distinct effects on growth and differentiation of intestinal epithelium. For these studies the co-culture system with two phenotypically distinct intestinal fibroblast subtypes that preferentially mediate proliferation (A1:F1 cells) or differentiation (F1:G9 cells) of intestinal endoderm.
Specific aim 4 will derive transgenic mice with alpha-SM-actin promoter (SMP) mediated over-expression of des-IGF-I, an analog of IGF-I with low affinity for IGFBPs, to test the hypothesis that IGFBPs modulate the cell specific autocrine/paracrine actions of IGF-I in bowel in vivo.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
May, Michael K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Schools of Medicine
Chapel Hill
United States
Zip Code
Kechele, Daniel O; Blue, R Eric; Zwarycz, Bailey et al. (2017) Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formation. J Clin Invest 127:593-607
Andres, Sarah F; Santoro, M Agostina; Mah, Amanda T et al. (2015) Deletion of intestinal epithelial insulin receptor attenuates high-fat diet-induced elevations in cholesterol and stem, enteroendocrine, and Paneth cell mRNAs. Am J Physiol Gastrointest Liver Physiol 308:G100-11
Van Landeghem, Laurianne; Santoro, M Agostina; Mah, Amanda T et al. (2015) IGF1 stimulates crypt expansion via differential activation of 2 intestinal stem cell populations. FASEB J 29:2828-42
Poindexter, Shenika V; Reddy, Vishruth K; Mittal, Mukul K et al. (2015) Transcriptional corepressor MTG16 regulates small intestinal crypt proliferation and crypt regeneration after radiation-induced injury. Am J Physiol Gastrointest Liver Physiol 308:G562-71
Santoro, M Agostina; Blue, R Eric; Andres, Sarah F et al. (2015) Obesity and intestinal epithelial deletion of the insulin receptor, but not the IGF 1 receptor, affect radiation-induced apoptosis in colon. Am J Physiol Gastrointest Liver Physiol 309:G578-89
Mah, Amanda T; Van Landeghem, Laurianne; Gavin, Hannah E et al. (2014) Impact of diet-induced obesity on intestinal stem cells: hyperproliferation but impaired intrinsic function that requires insulin/IGF1. Endocrinology 155:3302-14
Santoro, M Agostina; Andres, Sarah F; Galanko, Joseph A et al. (2014) Reduced insulin-like growth factor I receptor and altered insulin receptor isoform mRNAs in normal mucosa predict colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 23:2093-100
Andres, Sarah F; Simmons, James G; Mah, Amanda T et al. (2013) Insulin receptor isoform switching in intestinal stem cells, progenitors, differentiated lineages and tumors: evidence that IR-B limits proliferation. J Cell Sci 126:5645-56
Hamilton, Kathryn E; T├ętreault, Marie-Pier; Lund, P Kay (2013) Opportunities and challenges for women PhD investigators in gastrointestinal research. Gastroenterology 145:266-71
Van Landeghem, Laurianne; Santoro, M Agostina; Krebs, Adrienne E et al. (2012) Activation of two distinct Sox9-EGFP-expressing intestinal stem cell populations during crypt regeneration after irradiation. Am J Physiol Gastrointest Liver Physiol 302:G1111-32

Showing the most recent 10 out of 45 publications